Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), Viatris (VTRS)

Tipranks - Tipranks - Wed Mar 25, 3:05AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Siemens Healthineers AG (SEMHF), Viatris (VTRS) and Cooper Co (COO) with bullish sentiments.

Claim 30% Off TipRanks Premium

Siemens Healthineers AG (SEMHF)

In a report released today, James Vane from Jefferies maintained a Buy rating on Siemens Healthineers AG, with a price target of EUR60.00. The company’s shares closed last Monday at $43.31.

Vane has an average return of 1.2% when recommending Siemens Healthineers AG. ;'>

According to TipRanks.com, Vane is ranked #10861 out of 12128 analysts.

Currently, the analyst consensus on Siemens Healthineers AG is a Strong Buy with an average price target of $63.59, representing a 46.8% upside. In a report issued on March 11, Barclays also maintained a Buy rating on the stock with a EUR59.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Viatris (VTRS)

Barclays analyst Glen Santangelo maintained a Buy rating on Viatris today and set a price target of $17.00. The company’s shares closed last Monday at $13.29, close to its 52-week high of $13.55.

According to TipRanks.com, Santangelo is a 4-star analyst with an average return of 4.7% and a 50.2% success rate. Santangelo covers the Healthcare sector, focusing on stocks such as Bausch Health Companies, Amneal Pharmaceuticals, and Elanco Animal Health. ;'>

Currently, the analyst consensus on Viatris is a Moderate Buy with an average price target of $15.25, implying a 13.9% upside from current levels. In a report issued on March 20, Truist Financial also maintained a Buy rating on the stock.

Cooper Co (COO)

In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Cooper Co, with a price target of $103.00. The company’s shares closed last Monday at $70.24.

According to TipRanks.com, Miksic is a 4-star analyst with an average return of 2.7% and a 51.5% success rate. Miksic covers the Healthcare sector, focusing on stocks such as Anteris Technologies Global Corp., GE Healthcare Technologies Inc, and Orchestra BioMed Holdings. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cooper Co with a $89.70 average price target.

Read More on SEMHF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).